Differences in Protein Features Between Malignant and Benign Breast Cancers
Author Information
Author(s): Ebrahimi Mansour, Ebrahimie Esmaeil, Shamabadi Narges, Ebrahimi Mahdi
Primary Institution: Qom University, Iran
Hypothesis
Are there any differences between features of proteins expressed in malignant and benign breast cancers?
Conclusion
The frequency of the Ile-Ile dipeptide is a key protein attribute that helps distinguish between malignant and benign breast cancers.
Supporting Evidence
- The N-terminal amino acid was found to be Met in all proteins studied.
- 57 out of 838 protein features were ranked as important.
- The best performance was observed with the C&RT model.
Takeaway
This study looked at proteins in breast cancer and found that certain proteins can help tell if the cancer is serious or not.
Methodology
The study compared protein features in benign and malignant breast cancers using various screening techniques and decision tree models.
Limitations
The study focused on a limited number of protein attributes and may not capture all relevant features.
Participant Demographics
10 benign and 5 malignant breast cancer samples were analyzed.
Statistical Information
P-Value
p > 0.05 for 57 out of 838 attributes
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website